Skip to main content
Clinical Trials/JPRN-jRCT1030220303
JPRN-jRCT1030220303Recruiting未知

Cross-sectional analysis of psychiatric disorders based on AMPA receptor density

Miyazaki Tomoyuki0 sites219 target enrollmentStarted: August 31, 2022Last updated:

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
219

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
>= 20age old to <= 59age old (—)
Sex
All

Inclusion Criteria

  • The data must be from a pilot study (UMIN000025132) to compare the efficacy of the radioligand [11C]K-2 in the development of cross-disease diagnostics in depression, bipolar disorder, schizophrenia, addiction, ASD, epilepsy, FTD cases and healthy controls, and [11C]K-2 imaging data and MRI imaging data stored in the Department of Physiology, Yokohama City University, which can be analyzed in patients with depression, bipolar disorder, schizophrenia and ASD and in healthy controls.
  • The data were obtained in the 'A clinical trial to examine age-and-sex-related changes of AMPA receptor density in healthy volunteers.' and the data should be analyzable in males in their 20s-40s.
  • The data should be from [11C]K-2 images and MRI images taken in a cross-sectional PET study using [11C]K-2 (jRCTs031190197) and stored in the Department of Physiology, Yokohama City University, and should be available for analysis.
  • The data must be from [11C]K-2 imaging data and MRI imaging data taken in a cross-sectional PET study using [11C]K-2 (jRCTs031190150) and stored in the Department of Physiology, Yokohama City University, and must be available for analysis.
  • The data must be from [11C]K-2 imaging data and MRI imaging data taken in a cross-sectional PET study using [11C]K-2 (jRCTs031190149) and stored in the Department of Physiology, Yokohama City University, and must be available for analysis.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Miyazaki Tomoyuki

Similar Trials